Correction: This article has been corrected to relect that this is not a new suit, but rather a lawsuit that is a couple of years old that was transferred from Maryland to Texas. Court documents did not disclose that the suit was transferred, but rather was listed as a new filing.

NEW YORK (GenomeWeb News) – A lawsuit that Invitrogen, a division of Life Technologies, filed against GE Healthcare a couple of years ago alleging infringement of several patents held by Invitrogen has been transferred to a Texas court from Maryland.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: factors influencing retrotransposon integration sites, and more.

A bioethicist argues for the responsible use of germline gene editing.

Some breweries are using DNA-based testing to determine whether unwanted bacteria are affecting their beers, The Verge reports.

Standardized N-of-1 trials will be needed to test out personalized medicines, writes Nicholas Schork from the J. Craig Venter Institute at Nature.